GTBPVSSOPH• 6 Months (Normalized)
GTBP vs SOPH (GT Biopharma Inc. vs SOPHiA GENETICS SA)
Showing Closing Date Range from Apr 9 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.16
+1479.49%
GT Biopharma Inc.
Normalized Baseline0.00%
SOPH Performance $8.2
+73.36%
SOPHiA GENETICS SA
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1406.13 pts
GTBP outperforming by 1406.13 percentage points
GTBPSOPH
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SOPH
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | GTBP Price | GTBP Gain (%) | SOPH Price | SOPH Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $6.16 | +1479.49% | $8.20 | +73.36% | +1406.13% |
| Oct 02, 2026 | $6.10 | +1464.10% | $8.07 | +70.61% | +1393.49% |
| Sep 30, 2026 | $- | $8.38 | +77.17% | - | |
| Sep 29, 2026 | $6.88 | +1662.82% | $8.30 | +75.48% | +1587.34% |
| Sep 28, 2026 | $6.80 | +1643.59% | $8.49 | +79.49% | +1564.10% |
| Sep 25, 2026 | $6.89 | +1666.67% | $8.34 | +76.32% | +1590.35% |
| Sep 24, 2026 | $6.83 | +1651.28% | $8.26 | +74.63% | +1576.65% |
| Sep 23, 2026 | $7.10 | +1720.51% | $8.08 | +70.82% | +1649.69% |
| Sep 22, 2026 | $- | $8.07 | +70.61% | - | |
| Sep 21, 2026 | $7.18 | +1741.03% | $8.24 | +74.21% | +1666.82% |
| Sep 18, 2026 | $7.16 | +1735.90% | $8.19 | +73.15% | +1662.75% |
| Sep 17, 2026 | $7.49 | +1820.51% | $8.53 | +80.34% | +1740.17% |
| Sep 16, 2026 | $7.81 | +1902.56% | $7.98 | +68.60% | +1833.96% |
| Sep 15, 2026 | $9.00 | +2207.69% | $7.96 | +68.29% | +2139.40% |
| Sep 14, 2026 | $11.63 | +2882.05% | $7.86 | +66.17% | +2815.88% |
Page 1 of 9